Company Performance Metrics
- John Husnik: Chief Executive Officer, Co-Founder & Director
- Maurice Boucher: Co-Founder, Executive Chairman
The Company is in the applied life sciences industry with a focus on proprietary yeast-based technology platforms to develop functional, market-ready microorganisms for the global healthcare, agriculture, food and beverage, and chemicals industries. Current research and new product development: World’s first oral delivery system for RNA
RNAi production and delivery for gastrointestinal therapies for animal and human, RNAi production and delivery as a biopesticide for crop protection. Their current products include commercially available yeast strains that prevent the formation of two separate and significant naturally occurring contaminants: acrylamide in carbohydrate-rich foods and coffee, and hydrogen sulfide in wine, beer, and cider.
It was founded in 2013 by John Husnick and Maurice Boucher. It is headquartered in Vancouver, British Columbia.
